GO Term | Evidence Code | PMID |
---|---|---|
response to fatty acid | ||
positive regulation of interleukin-13 production | ||
cellular response to platelet-derived growth factor stimulus | ||
microglial cell activation | ||
cellular response to oxidised low-density lipoprotein particle stimulus |
GO Term | Evidence Code | PMID |
---|---|---|
receptor complex |
GO Term | Evidence Code | PMID |
---|---|---|
signaling receptor activity | ||
protein heterodimerization activity | ||
lipopolysaccharide binding | ||
NAD+ nucleotidase, cyclic ADP-ribose generating | ||
transmembrane signaling receptor activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:5614 | eye disease | |
DOID:5844 | myocardial infarction | |
DOID:612 | primary immunodeficiency disease | |
DOID:684 | hepatocellular carcinoma | |
DOID:7147 | ankylosing spondylitis | |
DOID:783 | end stage renal disease | |
DOID:848 | arthritis | |
DOID:850 | lung disease | |
DOID:854 | collagen disease | |
DOID:8677 | perinatal necrotizing enterocolitis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.1.1
Last updated: February 17, 2025